Please find below the abstract of the article entitled “Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study”, which was written in English by Alistair D Nichol, Moritoki Egi, Ville Pettila, Rinaldo Bellomo, Craig French,Graeme Hart, Andrew Davies, Edward Stachowski, Michael C Reade, Michael Bailey and David James Cooper, and published in Critical Care 2010, 14:R25

“Introduction: Higher lactate concentrations within the normal reference range (relative hyperlactatemia) are not considered clinically significant. We tested the hypothesis that relative hyperlactatemia is independently associated with an increased risk of hospital death.

Methods: This observational study examined a prospectively obtained intensive care database of 7,155 consecutive critically ill patients admitted to the Intensive Care Units (ICUs) of four Australian university hospitals. We assessed the relationship between ICU admission lactate, maximal lactate and time-weighted lactate levels and hospital outcome in all patients and also in those patients whose lactate concentrations (admission n = 3,964, maximal n = 2,511, and time-weighted n = 4,584) were under 2 mmol.L^-1 (i.e. relative hyperlactatemia).

Results:  We obtained 172,723 lactate measurements. Higher admission and time-weighted lactate concentration within the reference range was independently associated with increased hospital mortality (admission odds ratio (OR) 2.1, 95% confidence interval (CI) 1.3 to 3.5, P = 0.01; time-weighted OR 3.7, 95% CI 1.9 to 7.00, P < 0.0001). This significant association was first detectable at lactate concentrations > 0.75 mmol.L^-1. Furthermore, in patients whose lactate ever exceeded 2 mmol.L^-1, higher time-weighted lactate remained strongly associated with higher hospital mortality (OR 4.8, 95% CI 1.8 to 12.4, P < 0.001).

Conclusions: In critically ill patients, relative hyperlactataemia is independently associated with increased hospital mortality. Blood lactate concentrations > 0.75 mmol.L^-1 can be used by clinicians to identify patients at higher risk of death. The current reference range for lactate in the critically ill may need to be re-assessed.“

Please click here to access the full article: